INFINITY PHARMACEUTICALS, INC. - FORM 10-Q/A - EX-32.1 - CERTIFICATION OF PEO AND PFO PURSUANT TO 18 U.S.C.1350 - March 15, 2011

Attached files

file filename
EX-31.1 - CERTIFICATION OF PEO AND PFO PURSUANT TO RULE 13A-14(A)/15D-14(A) - INFINITY PHARMACEUTICALS, INC.dex311.htm
10-Q/A - FORM 10-Q AMENDMENT - INFINITY PHARMACEUTICALS, INC.d10qa.htm

EXHIBIT 32.1

STATEMENT PURSUANT TO 18 U.S.C. §1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. §1350, the undersigned certifies that this Quarterly Report on Form 10-Q/A for the period ended September 30, 2010 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of Infinity Pharmaceuticals, Inc.

 

   
Date: March 15, 2011     /s/ Adelene Q. Perkins
    Adelene Q. Perkins
    President and Chief Executive Officer
   

(Principal Executive and Principal Financial Officer)

A signed original of this written statement required by Section 906 has been provided to Infinity Pharmaceuticals, Inc. and will be retained by Infinity Pharmaceuticals, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

INFINITY PHARMACEUTICALS, INC. Reports